Organ, Tissue Harvesting Industry Safe, According to FDA Report
The FDA has reported that there are no significant problems in the nation's organ harvesting industry. The report comes less than a year after the formation of the Human Tissue Task Force, a group charged with evaluating the effectiveness of the agency's tissue regulations.
Over a period of six months, beginning last October, agents from the FDA's Office of Regulatory Affairs (ORA) inspected 153 major tissue recovery businesses, finding no major inaccuracies or deficiencies that would jeopardize the public health.
Safety problems in the industry have been exposed by a series of recent scandals, the largest involving Biomedical Tissue Services of New Jersey. The operator of that company has been charged with stealing corpses and unlawfully dissecting them to sell organs. Many funeral home directors have already plead guilty to crimes involving the company.
All recent organ harvesting scandals have involved businesses which lacked accreditation by the American Association of Tissue Banks, an organization that imposes more stringent safety standards than the FDA requires. Membership in the organization is strictly voluntary, however. The FDA requires no accreditation of tissue handling businesses.
We have posted articles about the lax inspection of transplant organs previously on the DC Metro Medical Malpractice Blog.
If you or a family member believe that you have a case involving inappropriate organ transplantation or medical malpractice, please contact us on-line at Regan Zambri & Long or call us at 202-463-3030 for a free consultation. If you would like to receive our complimentary electronic newsletter, please click here.
Over a period of six months, beginning last October, agents from the FDA's Office of Regulatory Affairs (ORA) inspected 153 major tissue recovery businesses, finding no major inaccuracies or deficiencies that would jeopardize the public health.
Safety problems in the industry have been exposed by a series of recent scandals, the largest involving Biomedical Tissue Services of New Jersey. The operator of that company has been charged with stealing corpses and unlawfully dissecting them to sell organs. Many funeral home directors have already plead guilty to crimes involving the company.
All recent organ harvesting scandals have involved businesses which lacked accreditation by the American Association of Tissue Banks, an organization that imposes more stringent safety standards than the FDA requires. Membership in the organization is strictly voluntary, however. The FDA requires no accreditation of tissue handling businesses.
We have posted articles about the lax inspection of transplant organs previously on the DC Metro Medical Malpractice Blog.
If you or a family member believe that you have a case involving inappropriate organ transplantation or medical malpractice, please contact us on-line at Regan Zambri & Long or call us at 202-463-3030 for a free consultation. If you would like to receive our complimentary electronic newsletter, please click here.